Abbvie Inc Stock Alpha and Beta Analysis
| ABBV Stock | USD 171.56 2.14 1.23% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as AbbVie Inc. It also helps investors analyze the systematic and unsystematic risks associated with investing in AbbVie over a specified time horizon. Remember, high AbbVie's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to AbbVie's market risk premium analysis include:
Beta 0.19 | Alpha (0.13) | Risk 2.17 | Sharpe Ratio (0.04) | Expected Return (0.1) |
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
AbbVie |
AbbVie Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. AbbVie market risk premium is the additional return an investor will receive from holding AbbVie long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in AbbVie. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate AbbVie's performance over market.| α | -0.13 | β | 0.19 |
AbbVie expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of AbbVie's Buy-and-hold return. Our buy-and-hold chart shows how AbbVie performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.AbbVie Market Price Analysis
Market price analysis indicators help investors to evaluate how AbbVie stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading AbbVie shares will generate the highest return on investment. By understating and applying AbbVie stock market price indicators, traders can identify AbbVie position entry and exit signals to maximize returns.
AbbVie Return and Market Media
The median price of AbbVie for the period between Sun, Oct 20, 2024 and Sat, Jan 18, 2025 is 176.83 with a coefficient of variation of 5.55. The daily time series for the period is distributed with a sample standard deviation of 9.99, arithmetic mean of 179.81, and mean deviation of 8.12. The Stock received substential amount of media coverage during this period. Price Growth (%) |
| Timeline |
| AbbVie dividend paid on 15th of November 2024 | 11/15/2024 |
1 | Disposition of 30288 shares by Timothy Richmond of AbbVie at 177.71 subject to Rule 16b-3 | 12/06/2024 |
2 | Disposition of 87050 shares by Richard Gonzalez of AbbVie at 61.36 subject to Rule 16b-3 | 12/20/2024 |
3 | AbbVie Benefitted from Top-Line Growth From Its Immunosuppressive Drugs | 12/23/2024 |
4 | AbbVie Upgraded to Buy What Does It Mean for the Stock | 12/31/2024 |
5 | AbbVie cuts 2024 profit forecast on acquisition expenses | 01/06/2025 |
6 | 8,318 Shares in AbbVie Inc. Bought by InvesTrust | 01/08/2025 |
7 | AbbVie Announces 3.5 Billion Impairment Charge on Emraclidine Asset | 01/10/2025 |
8 | AbbVie Inc. Shares Sold by Moody National Bank Trust Division | 01/13/2025 |
9 | AbbVie Inc. An Undervalued Dividend Kings Stock to Invest in Now | 01/14/2025 |
10 | AbbVies 3.5 Billion Blow Can Bold Bets Revive Its Profit Forecasts | 01/15/2025 |
About AbbVie Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including AbbVie or other stocks. Alpha measures the amount that position in AbbVie Inc has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
| 2022 | 2023 | 2024 | 2025 (projected) | Dividend Yield | 0.0351 | 0.0385 | 0.0346 | 0.0289 | Price To Sales Ratio | 4.93 | 5.04 | 4.54 | 3.39 |
AbbVie Upcoming Company Events
As portrayed in its financial statements, the presentation of AbbVie's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, AbbVie's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of AbbVie's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of AbbVie. Please utilize our Beneish M Score to check the likelihood of AbbVie's management manipulating its earnings.
| 2nd of February 2024 Upcoming Quarterly Report | View | |
| 25th of April 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 2nd of February 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Build Portfolio with AbbVie
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Additional Tools for AbbVie Stock Analysis
When running AbbVie's price analysis, check to measure AbbVie's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AbbVie is operating at the current time. Most of AbbVie's value examination focuses on studying past and present price action to predict the probability of AbbVie's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AbbVie's price. Additionally, you may evaluate how the addition of AbbVie to your portfolios can decrease your overall portfolio volatility.